Pathology Network

Skip Navigation Links
BlogExpand Blog
Information and ServicesExpand Information and Services
Skip Navigation LinksHome > Blogs > Image of the Week > Breast Mass in 75-year-old Woman
Image of the Week
Edited and moderated by Stacey Mills, MD, Pathology Network's Image of the Week Blog is a forum for the discussion of interesting and often diagnostically challenging pathology images.
Monday, July 15, 2013
Breast Mass in 75-year-old Woman
A 75-year-old woman presented with a breast mass and underwent an excision (lumpectomy).  The resultant specimen was referred to us for consultation.  The specimen consisted of scattered mildly hyperplastic ducts embedded in a variably but generally hypocellular spindle cell stroma, as shown below.
At higher magnification (seen above), there were mild to scattered moderately pleomorphic cells, and scattered mitotic figures including apparently atypical forms could be identified.  A broad spectrum cytokeratin cocktail (see below) showed strong positivity in the spindled cells. 
An immunohistochemical stain for p63 (see below), was also positive in the spindle cell population, as well as in myoepithelial cells surrounding the intralesional benign ducts.
This is an example of a metaplastic carcinoma of the breast with a sarcomatoid phenotype in which an accompanying malignant glandular component is not present, at least in the available material.  The sarcomatous elements in this case are relatively low grade and the term "spindle cell carcinoma" has been applied to similar tumors.  Although metaplastic carcinomas as a group appear to have a relatively poor prognosis, the better differentiated lesions, such as the current case appear to fare better (though prognosis remains to be completely defined).  As might be expected for a more stromal-like lesion, metastases to regional lymph nodes have been said to be less common, as opposed to hematogenous spread.
The take home message from this case is simply to not under diagnose the relatively bland and modestly cellular stroma as a benign process.  I high index of suspicion, as well as a broad spectrum cytokeratin cocktail (not just AE1/AE3) and p63, should aid in the recognition of this neoplasm.
Stuart M. Graham said:
Great case. Which broad spectrum keratin IHC was utilized for this case (and is shown in the photomic)? This is our cocktail. Unfortunately this won't format very well here: UVA Keratin Cocktail MAK-6- a combination of 2 mouse monoclonal antibodies against keratin numbers 8, 14, 15, 16, 18, & 19. AE1/AE3- a combination of 2 mouse monoclonal antibodies against keratins of 65-67, 64, 59, 58, 56.5, 56, 54, 52, 50, 40 & 48 kD. CAM5.2- a mouse monoclonal antibody against keratins of 7, 8, 48, & 52 kD. MNF116- a mouse monoclonal antibody against keratin numbers 5, 6, 8, 17, & 19. OSCAR- a mouse monoclonal antibody against keratins of 40, 48, 56.5, 50, 52, 58, 58, 59, 64, 65, & 67 kD. 35BH11- a mouse monoclonal antibody against 54 kD keratin. 34BE12- a mouse monoclonal antibody against keratins 1, 5, 10, & 14.
About the Author

Stacey E. Mills, MD
Stacey E. Mills, MD, a graduate of University of Virginia (UVA) and the UVA Medical Center, has authored nearly 230 articles, 20+ books, atlases and monographs—including the renowned Sternberg's Diagnostic Surgical Pathology. He has been a practicing Professor and Staff Pathologist at UVA for 30+ years and is Director of Surgical Pathology and Cytopathology. His clinical specialty is general surgical pathology with emphasis on neoplasms and neoplasm-like lesions. Dr. Mills is also Editor-in-Chief of The American Journal of Surgical Pathology.